Abstract:Cytosine, a DNA and RNA building-block, and Metformin, the most widely prescribed drug for the treatment of Type 2 Diabetes mellitus were made to react separately with ammonium or sodium metavanadates in acidic aqueous solutions to obtain two polyoxovanadate salts with a 6:1 ratio of cation-anion. Thus, compounds [HCyt]6[V10O28]·4H2O, 1 and [HMetf]6[V10O28]·6H2O, 2 (where HCyt = Cytosinium cation, [C4H6N3O]+ and HMetf = Metforminium cation, [C4H12N5]+) were obtained and characterized by elemental analysis, single crystal X-ray diffraction, vibrational spectroscopy (IR and Raman), solution 51V-NMR, thermogravimetric analysis (TGA-DTGA), as well as, theoretical methods. Both compounds crystallized in P 1 ¯ space group with Z' = 1/2, where the anionic charge of the centrosymmetric ion [V10O28]6- is balanced by six Cytosinium and six Metforminium counterions, respectively. Compound 1 is stabilized by π-π stacking interactions coming from the aromatic rings of HCyt cations, as denoted by close contacts of 3.63 Å. On the other hand, guanidinium moieties from the non-planar HMetf in Compound 2 interact with decavanadate μ2-O atoms via N-H···O hydrogen bonds. The vibrational spectroscopic data of both IR and Raman spectra show that the dominant bands in the 1000-450 cm-1 range are due to the symmetric and asymmetric ν(V-O) vibrational modes. In solution, 51V-NMR experiments of both compounds show that polyoxovanadate species are progressively transformed into the monomeric, dimeric and tetrameric oxovanadates. The thermal stability behavior suggests a similar molecular mechanism regarding the loss of water molecules and the decomposition of the organic counterions. Yet, no changes were observed in the TGA range of 540-580°C due to the stability of the [V10O28]6- fragment. Dispersion-corrected density functional theory (DFT-D) calculations were carried out to model the compounds in aqueous phase using a polarized continuum model calculation. Optimized structures were obtained and the main non-covalent interactions were characterized. Biological activities of these compounds are also under investigation. The combination of two therapeutic agents opens up a window toward the generation of potential metalopharmaceuticals with new and exciting pharmacological properties.

Synthesis, crystal structures and anticancer activities of two decavanadate compounds

Two Metal–Organic Coordination Polymers Based on Polypyridyl Ligands: Crystal Structures and Inhibition of Human Spinal Tumour Cells

Synthesis And Biological Evaluation Of Decavanadate Na4co(H2o)(6)V10o28 Center Dot 18h(2)O

Synthesis, Crystal Structure and Dna Binding Studies of Bis(Piperidinium) Bis-(N,N,N ',N '-Tetramethylethylenediammonium) Decavanadate(V) Tetrahydrate

Synthesis and biological evaluation of decavanadate Na4Co(H2O)6V10O28.18H2O.

Crystal Structures, Interactions with Biomacromolecules and Anticancer Activities of Mn(II), Ni(II), Cu(II) Complexes of Demethylcantharate and 2-Aminopyridine

Synthesis,in Vitrocytotoxicity, and Structure–activity Relationships (SAR) of Multidentate Oxidovanadium(iv) Complexes As Anticancer Agents

Synthesis, Structural Characterization, and Properties of Two New Polyoxovanadates Based on Decavanadate [V10O28]6−

Exploring Anticancer Activities and Structure–Activity Relationships of Binuclear Oxidovanadium(IV) Complexes

Decavanadate Salts of Cytosine and Metformin: A Combined Experimental-Theoretical Study of Potential Metallodrugs Against Diabetes and Cancer

Three Novel Organic-Inorganic Hybrid Materials Based on Decaoxovanadates Obtained from a New Liquid Phase Reaction

Exploring the Antitumor Efficacy of N-Heterocyclic Nitrilotriacetate Oxidovanadium(IV) Salts on Prostate and Breast Cancer Cells

Crystal Structures, Dna Interaction and Growth Inhibitory Activities of the Cobalt(Ii) and Nickel(Ii) Complexes of 2-Aminothiazole with Demethylcantharate

Decavanadate-Bearing Guanidine Derivatives Developed as Antimicrobial and Antitumor Species

Synthesis, Crystal Structure and Properties of Tetra(Piperidinium)Bis(Ethanolate) Decavanadate

Vanadium(v) complexes derived from triphenylphosphonium and hydrazides: cytotoxicity evaluation and interaction with biomolecules

Polyoxovanadate-iodobodipy Supramolecular Assemblies: New Agents for High Efficiency Cancer Photochemotherapy

SYNTHESIS, CHARACTERIZATION AND CRYSTAL STRUCTURE OF A NOVEL DECAVANADATE SALT, [V0.50(H2O)5]2[H2(V10O28)]·4(H2O)

Synthesis, physicochemical and pharmacological characterizations of a tetra-[methylimidazolium] dihydrogen decavanadate, inhibiting the IGR39 human melanoma cells development

Crystal Structures, DNA Interaction and Antiproliferative Activities of the Cobalt(ii) and Zinc(ii) Complexes of 2-Amino-1,3,4-thiadiazole with Demethylcantharate

Tris[(3-Aminopropyl)Dimethylammonium] Decavanadate(V) Hexahydrate